Breaking News
  • Flu vaccine coverage remains low this year

    As of early November, only about 2 out of 5 people in the United States reported having gotten this season’s flu vaccine, yet flu vaccine offered substantial benefit last season by preventing an estimated 5 million flu illnesses and 71,000 flu hospitalizations. CDC is releasing this information during the 11th National Influenza Vaccination Week (NIVW), an event to encourage ongoing flu vaccination into the holidays and beyond.

    http://cdc.gov

  • Sample News Two

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus sollicitudin, ligula eu cursus pharetra, turpis lacus sagittis quam, eu dictum neque justo eu ante. In vel viverra felis, eget sodales mauris. Nullam nulla neque, fermentum non libero non, luctus luctus est. Donec in justo vulputate, tincidunt turpis eget, placerat orci. Morbi venenatis tortor at augue pretium, quis finibus enim facilisis. Ut cursus purus eu euismod vehicula. Praesent ullamcorper faucibus orci, in varius leo semper at.

    Vivamus suscipit eros sed metus venenatis commodo. Aliquam lobortis, nunc id hendrerit volutpat, neque odio porttitor risus, non vehicula dolor tellus eu massa. Etiam dapibus nulla vel dui luctus auctor. Donec in egestas mi, at vehicula quam. Maecenas tempus blandit nisi sed ullamcorper. Maecenas ante turpis, eleifend et eros sit amet, fringilla dapibus neque. Mauris porta sapien nec risus hendrerit, non interdum diam tincidunt. Duis eu quam tempor, venenatis purus dictum, efficitur ligula.

    Donec non venenatis tellus. Mauris posuere felis id eros convallis, at consequat massa maximus. Maecenas eu posuere dolor. Proin vestibulum nec nisi ultricies facilisis. Phasellus nec rhoncus erat. Maecenas pulvinar, diam vitae lacinia malesuada, ipsum tellus volutpat urna, id facilisis ipsum massa ornare dui. Maecenas convallis egestas ultrices. Integer ut risus non diam egestas eleifend. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse volutpat ligula id ligula facilisis, a pellentesque ex placerat. Praesent porttitor et sapien nec dapibus. Proin a ipsum erat.

    Morbi tempus id leo in euismod. Aenean placerat felis mi, vitae tincidunt tellus dignissim vitae. Aenean vitae metus ante. Nunc iaculis, lacus ac vulputate vestibulum, eros purus condimentum nibh, in consectetur diam odio non neque. Vivamus auctor dolor nec erat semper pharetra. Vestibulum id aliquet augue. Vivamus vehicula, nulla a auctor maximus, nibh ante maximus quam, eget semper nulla erat nec nulla. Pellentesque vitae est nec nisi rhoncus iaculis. Pellentesque a gravida ipsum. Aliquam vulputate finibus odio, vel ullamcorper massa lacinia sagittis. Vivamus nec odio sit amet odio rutrum rhoncus vel eu augue. Curabitur dolor neque, varius et sem non, pharetra efficitur velit. Maecenas semper ultrices velit, id egestas diam mattis at. Integer sed molestie turpis, nec molestie nunc. Proin luctus efficitur congue.

    Praesent consequat leo ac neque porta sodales. Donec eleifend felis malesuada, fermentum neque aliquet, pharetra dui. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Donec in leo nec magna tincidunt facilisis. Curabitur semper sed nisl tincidunt feugiat. Nullam et mattis erat, in pharetra sem. Aenean mi enim, volutpat ut felis ac, hendrerit dapibus lorem. Maecenas laoreet ultricies vulputate.

  • Sample News Story

    M E M O R A N D U M

    DATE: August 2, 2016
    TO: Local Health Departments, Infection Control Practitioners, Healthcare Providers,
    Infectious Disease Physicians, Obstetricians, and Laboratories
    FROM: Communicable Disease Control Section (CDCS)
    SUBJECT: Travel and Testing Recommendations Related to Florida Travel

    The first local mosquito-borne Zika virus transmission in the continental United States has recently been identified in a specific region in Miami, FL (delineated area: http://www.cdc.gov/zika/intheus/florida-update.html). The Illinois Department of Public Health (IDPH) is issuing guidance put forth by the Centers for Disease Control and Prevention (CDC) for travel and testing of pregnant women and women of reproductive age who lived in, or traveled to, this area after June 15, 2016. The travel and testing recommendations are detailed below.

    Recommendations for Testing Pregnant Women and Women of Reproductive Age who Traveled to Miami-Dade County, FL

    •  Pregnant women should avoid non-essential travel to the area with active Zika virus transmission identified by the Florida Department of Health (FL DOH).
    •  Pregnant women and their partners living in, or traveling to, the area with active Zika virus transmission identified by the FL DOH should follow steps to prevent mosquito bites (http://www.cdc.gov/zika/prevention/prevent-mosquito-bites.html).
    •  Women and men who live in, or who have traveled to, the area with active Zika virus transmission identified by the FL DOH (Miami, FL) and who have a pregnant sex partner should consistently and correctly use condoms or other barriers to prevent infection during sex or not have sex for the duration of the pregnancy.
    •  Women and men with limited risk and who do not report signs or symptoms consistent with Zika virus disease should wait at least eight weeks after last possible exposure to attempt conception.
    •     All pregnant women in the United States should be assessed for possible Zika virus exposure during each prenatal care visit. Women with ongoing risk of possible exposure include those who live in or frequently travel to the area with active Zika virus transmission identified by the FL DOH. Women with limited risk include: 1) those who traveled infrequently to the area with active Zika virus transmission identified by the FL DOH, or 2) had sex with a partner who lives in or traveled to the area with active Zika virus transmission without using condoms or other barrier methods to prevent infection. Each evaluation should include an assessment of signs and symptoms of Zika virus disease (acute onset of fever, rash, arthralgia, conjunctivitis) and travel histories, as well as sexual partners’ potential Zika virus exposures AND history of any illness consistent with Zika virus disease, to determine whether Zika virus testing is indicated.
    •  Pregnant women with possible exposure to Zika virus and signs or symptoms consistent with Zika virus disease should be tested for Zika virus infection based on time of evaluation relative to symptom onset in accordance with CDC guidance (http://www.cdc.gov/mmwr/volumes/65/wr/mm6529e1.htm?s_cid=mm6529e1_e).

    Local health departments can approve Zika testing at IDPH’s Chicago Laboratory for pregnant women who traveled, or had sex with someone who traveled, to the specified area in Florida after June 15, 2016. Authorization for testing also can be given for symptomatic persons (2 or more symptoms), male or female, who traveled to this area during the specified time frame. Commercial laboratory testing for Zika virus is also available for this and other circumstances where Zika testing is indicated.

    As the CDC learns more about the epidemiologic trends in distribution, transmission, and effects of mosquito abatement efforts, these recommendations are subject to change, and new areas of active Zika virus transmission may be identified. For updated information on locally acquired cases, please check the CDC website (http://www.cdc.gov/zika/geo/united-states.html).

  • Flu vaccine coverage remains low this year

    • 12/13/2016 - 09:25
  • Sample News Two

    • 10/12/2016 - 12:46
  • Sample News Story

    • 10/11/2016 - 14:21

No front page content has been created yet.